News

Anheuser-Busch InBev embroiled in Caribbean "poison pill" takeover row

Most popular

Should Campari Group be renamed Aperol Group?

just-drinks speaks to A-B InBev CEO Carlos Brito

Campari Group's Aperol Q3 bonanza - Comment

just-drinks' M&A database - Oct 18

MORE

As Anheuser-Busch InBev awaits the green light from regulators over its SABMiller acquisition, its Brazilian subsidiary AmBev is battling investors in a fight for control of a Caribbean beverage company.


Related Content

Anheuser-Busch InBev moves closer to Craft Brew Alliance buy - analyst

Anheuser-Busch InBev moves closer to Craft Brew Alliance buy - analyst...

Anheuser-Busch InBev names new CMO, reduces regional management zones

Anheuser-Busch InBev names new CMO, reduces regional management zones...

Anheuser-Busch InBev in Africa - Focus

Anheuser-Busch InBev in Africa - Focus...

Anheuser-Busch InBev full-year 2017 results - Preview

Anheuser-Busch InBev full-year 2017 results - Preview...

Oops! This article is copy protected.

Why can’t I copy the text on this page?

The ability to copy articles is specially reserved for people who are part of a group membership.

How do I become a group member?

To find out how you and your team can copy and share articles and save money as part of a group membership call Sean Clinton on
+44 (0)1527 573 736 or complete this form..



Forgot your password?